Compound Detail
CHEMBL19490
ZOMEPIRAC 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL19490 |
| Name | ZOMEPIRAC |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | ZXVNMYWKKDOREA-UHFFFAOYSA-N |
1
Targets
6
Activities
2
Assay Types
4
PK Parameters
20
Publications
2
Known Names
1
Indications
Molecular Properties
291.7
MW (Da)
2.85
ALogP
3
HBA
1
HBD
59.3
PSA (Ų)
0.88
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1980 |
| Availability | Withdrawn |
| Chirality | Achiral |
Indications
Rheumatic Diseases
ATC Classification
M01AB04
zomepirac
Level 1: MUSCULO-SKELETAL SYSTEM
Level 2: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
Drug Warnings
Withdrawn
immune system toxicity
serious allergic reactions, including five deaths from anaphylaxis
Withdrawn
immune system toxicity
serious allergic reactions, including five deaths from anaphylaxis
Activity Summary
Ki 5 meas.
IC50 1 meas. best 4.82
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Cyclooxygenase CHEMBL2096674 | IC50 | 4.82 | 4.82 | 15000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 3.0 | uL.min-1.(10^6cells)-1 | Homo sapiens |
| CL | - | - | Homo sapiens |
| CL | - | - | Homo sapiens |
| T1/2 | 0.5 | hr | - |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Cyclooxygenase | IC50 | = | 15000.0 | nM | 4.82 | Inhibition of prostaglandin G/H synthase obtained from bovine seminal vesicles. | 6436487 |
Literature References
Data from ChEMBL 36 via Core Engine